Xencor | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Arrowhead Research USD 138.14M 137.91M 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Biogen USD 146.6M 146.5M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Cytokinetics USD 119.6M 119.48M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
J&J USD 3.12B 0 2025-03
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Xencor USD 71.3M 70.58M 2025-06


Xencor Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.